Cell And Gene Therapy Upstream Optimization

  1. Cell And Gene Therapy Innovations 5/19/2025

    This interview with a pharmaceutical analytics expert discusses key insights into advances in cell and gene therapy and the strategies used to support customers in improving their therapeutic development.

  2. How To Use 5 And 10L BPCs Of The CTS Optmizer Family Of Serum Free Media 6/2/2025

    Gibco™ CTS™ OpTmizer™ T Cell Expansion SFM, no phenol red, and Gibco™ CTS™ OpTmizer™ Pro SFM are now available in 5 L and 10 L volumes in Thermo Scientific™ BioProcess Containers.

  3. Supporting Efficacy And Scaling With A Next-Generation T Cell AOF Formulation Medium 6/16/2025

    Explore a novel, next-generation medium designed with an animal component-free formulation to boost therapeutic potential and enable reproducible T cells.

  4. Analytical Solutions To Help Accelerate Bioprocessing Success 11/1/2024

    Unlock the power of data-driven bioprocessing. Discover how advanced analytics can optimize your cell culture process, improve performance, and accelerate success.

  5. Dry Powder Media Manufacturing Grand Island Expansion 11/5/2025

    Take a video tour of our newly expanded dry powder media manufacturing facility in Grand Island, New York. The expansion has added more than 45,000 square feet of Animal Origin Free (AOF) manufacturing space to help meet increasing global demand.

  6. Driving Down COGS Audience Q&A 8/18/2023

    Expert panelists provide detailed answers to questions submitted in real time by our registrants providing insightful responses regarding analytical challenges to automation, test automation, and more.

  7. Inside Bioprocessing: Next Generation CHO Media And Feeds 11/19/2025

    Discussing the potential of next generation cell culture media and feed systems to enhance monoclonal antibody production.

  8. Perfusion: Medium Selection And Testing 6/16/2025

    An examination of what to consider in a perfusion medium, including varying reconstituted concentrations, supporting multiple cell clones, allowing for high cell densities at low medium exchange rates, and using it in various types of perfusion.

  9. Optimize Cell Isolation And Activation For Flexibility And Scalability 11/13/2023

    Learn about a first-of-its-kind platform technology that enables isolation and activation of T cells in one step using an active release mechanism for clinical trial or commercial manufacturing.

  10. Cell Therapy Bioprocessing Workflow Cinematic 5/28/2025

    Witness a seamless cell therapy bioprocessing workflow that reduces manufacturing time and preserves the crucial cell phenotype for scalable, effective autologous and allogeneic therapies.